![Mark Newman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Newman
Hoofd Techniek/Wetenschap/O&O bij
GEOVAX LABS
Vermogen: - $ op 31-10-2026
Profiel
Mark J.
Newman is the founder of Newmark Diagnostics LLC, founded in 2016.
Dr. Newman is currently Chief Scientific Officer at GeoVax Labs, Inc., a position held since 2020.
Former positions include Vice President-Research & Development at Epimmune, Inc. in 2005, Vice President-Research & Development at Emergent Travel Health, Inc. in 2009, Vice President-Research & Development at Pharmexa A in 2008, Vice President-Infectious Diseases at IDM Pharma, Inc. in 2011, and Vice President-Research & Development at GeoVax Labs, Inc. from 2010 to 2013.
Dr. Newman was also a Member at Louisiana State University.
Education includes undergraduate and graduate degrees from The Ohio State University and a doctorate from John Curtin School of Medical Research.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GEOVAX LABS, INC. -.--% | 28-08-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
Actieve functies van Mark Newman
| Bedrijven | Functie | Begin |
|---|---|---|
| GEOVAX LABS | Hoofd Techniek/Wetenschap/O&O | 25-08-2020 |
Eerdere bekende functies van Mark Newman
| Bedrijven | Functie | Einde |
|---|---|---|
| GEOVAX LABS | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Corporate Officer/Principal | 28-04-2011 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Hoofd Techniek/Wetenschap/O&O | 01-12-2009 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Hoofd Techniek/Wetenschap/O&O | 01-12-2008 |
Epimmune, Inc.
 Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Hoofd Techniek/Wetenschap/O&O | 01-12-2005 |
Opleiding van Mark Newman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Epimmune, Inc.
Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
GeoVax Labs, Inc.
 GeoVax Labs, Inc. BiotechnologyHealth Technology Develops vaccines for diseases caused by Human Immunodeficiency Virus and other infectious agents | Health Technology |
Newmark Diagnostics LLC | |
John Curtin School of Medical Research
 John Curtin School of Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
